L'Oréal's CEO told investors GLP-1s are shifting skincare buying, while Carlsberg and Diageo play down any hit to beer demand.
Recap by typeshit. Full story at Martin Cid Magazine.
General exercise advice aimed at GLP-1 users, shared on Facebook with no study or expert named in the material available.
Gilead takes global rights to the Shanghai biotech's program, led by HCXT-2001, an oral peptide that could compete with injected IBD drugs.
A Facebook promo for a podcast episode on the ripple effects of GLP-1 consumers across businesses. Few details beyond the pitch.
10:49
xitsnemox posts a short check-in from week 14 on oral Wegovy, two weeks after stepping up to the 25mg tablet. A personal account, not medical advice.
An NYU obesity doctor outlines what people considering Ozempic or similar drugs should watch for. It is a general explainer for anyone weighing the shots.
Researchers found a 44% relative drop over five years, though an outside expert told Newsweek that equals about 3 to 5 points. They also flag a lithium toxicity risk early on.
Loading…